US Patent 10577329 Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Patent 10577329 was granted and assigned to FORMA Therapeutics on March, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+217 characters)
Article
Patent abstract
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Ann-Marie Campbell0
Anna Ericsson0
David R. Lancia, Jr.0
Gary Gustafson0
Jian Lin0
Justin Andrew Caravella0
R. Bruce Diebold0
Susan Ashwell0
Wei Lu0
Zhongguo Wang0
Edits on 22 Apr, 2023
Golden AI
Infobox
Edits on 1 Apr, 2023
Golden AI
Infobox
Edits on 29 Mar, 2023
Golden AI
Edits on 28 Mar, 2023
Golden AI
Edits on 16 Nov, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 27 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Edits on 22 Sep, 2022
Golden AI
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
US Patent 10577329 Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10577329
Date of patent
March 3, 2020
Patent application number
16351457
Date Filed
March 12, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10577329 Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.